BILLERICA, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the William Blair & Co. 37th Annual Growth Stock Conference in Chicago, Illinois on Tuesday, June 13, 2017 at 12:50 p.m. (Central Time).
To listen to a live audio webcast of the presentation, please visit http://investors.insulet.com. A replay of the webcast will also be available following the event.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its Omnipod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The Omnipod is a revolutionary and easy-to-use tubeless insulin pump that provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet's Delivery Systems business also partners with global pharmaceutical and biotechnology companies to adapt the Omnipod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts. For more information, please visit: http://www.myomnipod.com.